Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Institut Regional Du Cancer De Montpellier
Sponsor

Institut Regional Du Cancer De Montpellier

France 208 Avenue Des Apothicaires, 34298 Montpellier, France

About the sponsor

Research activity includes metastatic colorectal cancer, colon cancer, and rectum cancer, with interest in treatment sequencing, response-driven management, and survival outcomes in advanced disease.

  • Metastatic colorectal cancer
  • Colon cancer
  • Rectum cancer

Clinical work in this area also reflects attention to personalized treatment selection and disease control after standard therapy failure.

About Specializations

Institut Regional Du Cancer De Montpellier runs clinical trials in conditions such as Pancreatic carcinoma, Breast cancer, Neuroendocrine tumour, Rectal cancer, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

6 clinical trials

Pancreatic carcinoma

Recruiting

Study on Sequential Treatment with Gemcitabine, Paclitaxel, and FOLFIRINOX for Patients with Locally Advanced Pancreatic Cancer

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Fluorouracil
  • Sponsor:Institut Regional Du Cancer De Montpellier

Breast cancer

Recruiting

Study on Pravastatin for Patients with Severe Radio-Induced Breast Fibrosis After Breast Cancer

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Pravastatin Sodium
  • Sponsor:Institut Regional Du Cancer De Montpellier

Neuroendocrine tumour

Recruiting

Study on Retreatment with Lutetium (177Lu) Oxodotreotide for Patients with Intestinal Neuroendocrine Tumors

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:L-Arginine Hydrochloride
  • Sponsor:Institut Regional Du Cancer De Montpellier

Rectal cancer

Recruiting

Study on Managing Locally-Advanced Rectal Cancer with Oxaliplatin, Fluorouracil, and Irinotecan Hydrochloride for Patients Responding Well to Initial Chemotherapy

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Institut Regional Du Cancer De Montpellier

Glioma

Not yet recruiting

Study on Quality of Life and Brain Function in Patients with Diffuse Low-Grade Gliomas Treated with Temozolomide

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Temozolomide
  • Sponsor:Institut Regional Du Cancer De Montpellier

Colorectal cancer metastatic

Not recruiting

Study Comparing Regorafenib and Regorafenib-Irinotecan Combination for Patients with Metastatic Colorectal Cancer After Standard Treatments Have Failed

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Irinotecan
  • Sponsor:Institut Regional Du Cancer De Montpellier

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.